Medicine Man Technologies, Inc., a prominent player in the cannabis industry, is headquartered in the United States. Founded in 2014, the company has established itself as a leader in the cultivation, production, and distribution of cannabis products, primarily serving the legal markets across several states. With a focus on innovative cultivation techniques and high-quality product offerings, Medicine Man Technologies stands out for its commitment to sustainability and compliance. The company provides a range of services, including consulting, licensing, and operational support for cannabis businesses, making it a valuable partner in the evolving landscape of the industry. Recognised for its strategic growth and market presence, Medicine Man Technologies continues to expand its footprint, contributing to the development of the cannabis sector while ensuring the highest standards of quality and safety.
How does Medicine Man Technologies, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Medicine Man Technologies, Inc.'s score of 19 is lower than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medicine Man Technologies, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, the organisation's climate commitments remain unclear, and it does not appear to have inherited any emissions data or targets from a parent company or corporate family. This lack of information suggests that Medicine Man Technologies, Inc. may need to enhance its transparency and commitment to climate action in line with industry standards.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Medicine Man Technologies, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
